American Journal of Physiology-Gastrointestinal and Liver PhysiologyPathologyPeer-reviewed journal article
Role of Long Chain Acyl-CoA Synthetases in MASH-driven Hepatocellular Carcinoma and Ferroptosis
Peyton Classon, Alexander Q. WixomiD, Natalia Calixto MancipeiD, Rondell Patrell GrahamiD, Yu ZhaoiD, Nguyen H. TraniD, Timuçin TaneriD, Davide PoveroiD
Abstract
Metabolic-associated steatohepatitis-driven hepatocellular carcinoma (MASH-HCC) incidence is rapidly rising worldwide. Lipid metabolic reprogramming is a hallmark of solid tumors to satisfy cancer high metabolic demand. However, it may confer sensitivity to ferroptosis, a cell death mode driven by iron-dependent lipid peroxidation. In this report, we describe the lipid metabolic landscape in MASH-HCC and characterize long chain acyl-CoA synthetases (ACSLs), a family of enzymes involved in synthesis of cellular lipids. Bulk RNA-sequencing, single-cell RNA-sequencing, spatial transcriptomics and immunohistochemistry analyses of human MASH-HCC were integrated to identify differentially expressed lipid metabolism genes. Ferroptosis in vitro was assessed in human HCC cell lines. A characterization of ACSLs was also conducted at the single-cell level in a diet-induced experimental murine model of MASH-HCC. Our analysis revealed that in human MASH-HCC, ACSLs exhibit a heterogeneous expression, with ACSL4 notably enriched in tumor tissues, contrasting with ACSL5 upregulation in non-cancerous MASH. We identified a unique lipid metabolic gene signature of MASH-HCC, which included genes associated with ferroptosis vulnerability. In vitro, ACSL4 upregulation was associated with increased ferroptosis sensitivity in human HCC cell lines. Lastly, single-cell RNA-sequencing revealed elevated ACSL4 expression in immune cells in a murine MASH-HCC model, suggesting a role of ACSL4 in shaping the tumor immune microenvironment. Overall, this report offers new insights into lipid metabolic landscape and ferroptosis sensitivity for novel MASH-HCC treatments. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=135 SRC="FIGDIR/small/642692v1_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@2ab7f7org.highwire.dtl.DTLVardef@93d903org.highwire.dtl.DTLVardef@8c8891org.highwire.dtl.DTLVardef@5a235e_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- assay: scRNA-seq
- assay: spatial transcriptomics
- assay: imaging
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: statistical model
- approach: experimental assay
- Citations
- 5
- FWCI
- 2.24
- Field percentile
- top 11%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD
Carolin Angendohr, Christiane Koppe, … Tom Luedde·Hepatology CommunicationsPeer-reviewed·May 16, 2025
- Hepatocyte MLKL Drives Obesity-Driven Hepatocellular Carcinoma Progression via Mitochondrial Dysfunction Independent of Necroptosis in MASLD
Phoebe Ohene-Marfo, Sabira Mohammed, … Sathyaseelan S. Deepa·HepatologyPeer-reviewed·Aug 4, 2026
- The Lipid Hydrolase ABHD6 is a Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular Carcinoma
Danny Orabi, William J. Massey, … J. Mark Brown·bioRxiv·Jul 29, 2025
- Transcriptomic Enrichment of Ferroptosis-Related Gene ACSL4 in Advanced Hepatic Fibrosis/Cirrhosis: Bioinformatics Analysis and Experimental validation
Shuya Zhang, Ying Liu, … Jun Huang·bioRxiv·Jun 22, 2023
- MASH-in-a-dish reveals fatty acid-driven itaconate crosstalk between Kupffer cells and hepatocytes
Jung-Chin Chang, Annika Sullock Enzlin, … Celia R. Berkers·bioRxiv·Nov 2, 2026
- MMD scaffolds ACSL4 and MBOAT7 to promote polyunsaturated phospholipid synthesis and susceptibility to ferroptosis
V. V. Phadnis, J. Snider, … R. A. Weinberg·bioRxiv·Sep 1, 2022